The company was founded in 2013 and is a high-tech biotechnology enterprise focused on providing cell culture solutions and end-to-end CDMO services. The company is a high-tech enterprise specializing in cell culture products and services. The company is based on cell culture technology and process development, and its main business involves two major application areas: cell culture medium series products and biopharmaceutical contract development and production services.
No Data